New York State Common Retirement Fund’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $140K | Buy |
+21,900
| New | +$140K | ﹤0.01% | 2406 |
|
|
2024
Q3 | – | Sell |
-444
| Closed | -$1K | – | 3181 |
|
|
2024
Q2 | $1K | Sell |
444
-20,800
| -98% | -$46.8K | ﹤0.01% | 3269 |
|
|
2024
Q1 | $60K | Sell |
21,244
-2,510
| -11% | -$7.09K | ﹤0.01% | 2925 |
|
|
2023
Q4 | $350K | Buy |
23,754
+2,519
| +12% | +$37.1K | ﹤0.01% | 2234 |
|
|
2023
Q3 | $389K | Sell |
21,235
-2,100
| -9% | -$38.5K | ﹤0.01% | 2153 |
|
|
2023
Q2 | $503K | Sell |
23,335
-3,396
| -13% | -$73.2K | ﹤0.01% | 2082 |
|
|
2023
Q1 | $784K | Sell |
26,731
-6,972
| -21% | -$204K | ﹤0.01% | 1950 |
|
|
2022
Q4 | $1.25M | Buy |
33,703
+10,297
| +44% | +$380K | ﹤0.01% | 1858 |
|
|
2022
Q3 | $659K | Buy |
23,406
+14,209
| +154% | +$400K | ﹤0.01% | 2190 |
|
|
2022
Q2 | $177K | Buy |
9,197
+5,197
| +130% | +$100K | ﹤0.01% | 2844 |
|
|
2022
Q1 | $51K | Buy |
+4,000
| New | +$51K | ﹤0.01% | 3166 |
|